Mustafa Khasraw, Mbchb, Md, Frcp, Fracp

This early-stage trial tests a vaccine made from small protein pieces (peptides) designed to train the immune system to attack glioblastoma, an aggressive brain cancer. It includes 24 adults with newly diagnosed, untreated tumors. The main goal is to check safety and find the rig…